BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38905847)

  • 21. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.
    Inoue H; Tani K
    Cell Death Differ; 2014 Jan; 21(1):39-49. PubMed ID: 23832118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
    Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
    J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer immunogenicity, danger signals, and DAMPs: what, when, and how?
    Garg AD; Dudek AM; Agostinis P
    Biofactors; 2013; 39(4):355-67. PubMed ID: 23900966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rediscovery of nanoparticle-based therapeutics: boosting immunogenic cell death for potential application in cancer immunotherapy.
    Yang S; Sun IC; Hwang HS; Shim MK; Yoon HY; Kim K
    J Mater Chem B; 2021 May; 9(19):3983-4001. PubMed ID: 33909000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine.
    Turubanova VD; Balalaeva IV; Mishchenko TA; Catanzaro E; Alzeibak R; Peskova NN; Efimova I; Bachert C; Mitroshina EV; Krysko O; Vedunova MV; Krysko DV
    J Immunother Cancer; 2019 Dec; 7(1):350. PubMed ID: 31842994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticle-mediated immunogenic cell death for cancer immunotherapy.
    Qi H; Li Y; Geng Y; Wan X; Cai X
    Int J Pharm; 2024 May; 656():124045. PubMed ID: 38561134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomedicines for an Enhanced Immunogenic Cell Death-Based
    Zhao C; Wang C; Shan W; Wang Z; Chen X; Deng H
    Acc Chem Res; 2024 Mar; 57(6):905-918. PubMed ID: 38417027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consensus guidelines for the detection of immunogenic cell death.
    Kepp O; Senovilla L; Vitale I; Vacchelli E; Adjemian S; Agostinis P; Apetoh L; Aranda F; Barnaba V; Bloy N; Bracci L; Breckpot K; Brough D; Buqué A; Castro MG; Cirone M; Colombo MI; Cremer I; Demaria S; Dini L; Eliopoulos AG; Faggioni A; Formenti SC; Fučíková J; Gabriele L; Gaipl US; Galon J; Garg A; Ghiringhelli F; Giese NA; Guo ZS; Hemminki A; Herrmann M; Hodge JW; Holdenrieder S; Honeychurch J; Hu HM; Huang X; Illidge TM; Kono K; Korbelik M; Krysko DV; Loi S; Lowenstein PR; Lugli E; Ma Y; Madeo F; Manfredi AA; Martins I; Mavilio D; Menger L; Merendino N; Michaud M; Mignot G; Mossman KL; Multhoff G; Oehler R; Palombo F; Panaretakis T; Pol J; Proietti E; Ricci JE; Riganti C; Rovere-Querini P; Rubartelli A; Sistigu A; Smyth MJ; Sonnemann J; Spisek R; Stagg J; Sukkurwala AQ; Tartour E; Thorburn A; Thorne SH; Vandenabeele P; Velotti F; Workenhe ST; Yang H; Zong WX; Zitvogel L; Kroemer G; Galluzzi L
    Oncoimmunology; 2014 Oct; 3(9):e955691. PubMed ID: 25941621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of miRNA:mRNA Co-Expression Revealed Crucial Mechanisms Modulated in Immunogenic Cancer Cell Death.
    Lamberti MJ; Montico B; Ravo M; Nigro A; Giurato G; Iorio R; Tarallo R; Weisz A; Stellato C; Steffan A; Dolcetti R; Casolaro V; Faè DA; Dal Col J
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging role of natural products in cancer immunotherapy.
    Dong S; Guo X; Han F; He Z; Wang Y
    Acta Pharm Sin B; 2022 Mar; 12(3):1163-1185. PubMed ID: 35530162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy.
    Rapoport BL; Anderson R
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenic Cell Death in Hematological Malignancy Therapy.
    Liu Z; Xu X; Liu K; Zhang J; Ding D; Fu R
    Adv Sci (Weinh); 2023 May; 10(13):e2207475. PubMed ID: 36815385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gold standard assessment of immunogenic cell death induced by photodynamic therapy: From in vitro to tumor mouse models and anti-cancer vaccination strategies.
    Mishchenko TA; Balalaeva IV; Turubanova VD; Saviuk MO; Shilyagina NY; Krysko O; Vedunova MV; Krysko DV
    Methods Cell Biol; 2024; 183():203-264. PubMed ID: 38548413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inducing immunogenic cell death in immuno-oncological therapies.
    Ti D; Yan X; Wei J; Wu Z; Wang Y; Han W
    Chin J Cancer Res; 2022 Feb; 34(1):1-10. PubMed ID: 35355932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death.
    Turubanova VD; Mishchenko TA; Balalaeva IV; Efimova I; Peskova NN; Klapshina LG; Lermontova SA; Bachert C; Krysko O; Vedunova MV; Krysko DV
    Sci Rep; 2021 Mar; 11(1):7205. PubMed ID: 33785775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.
    Aria H; Rezaei M
    Biomed Pharmacother; 2023 May; 161():114503. PubMed ID: 36921539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trial watch: chemotherapy-induced immunogenic cell death in oncology.
    Sprooten J; Laureano RS; Vanmeerbeek I; Govaerts J; Naulaerts S; Borras DM; Kinget L; Fucíková J; Špíšek R; Jelínková LP; Kepp O; Kroemer G; Krysko DV; Coosemans A; Vaes RDW; De Ruysscher D; De Vleeschouwer S; Wauters E; Smits E; Tejpar S; Beuselinck B; Hatse S; Wildiers H; Clement PM; Vandenabeele P; Zitvogel L; Garg AD
    Oncoimmunology; 2023; 12(1):2219591. PubMed ID: 37284695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic Cells Pulsed with Tumor Lysates Induced by Tetracyanotetra(aryl)porphyrazines-Based Photodynamic Therapy Effectively Trigger Anti-Tumor Immunity in an Orthotopic Mouse Glioma Model.
    Redkin TS; Sleptsova EE; Turubanova VD; Saviuk MO; Lermontova SA; Klapshina LG; Peskova NN; Balalaeva IV; Krysko O; Mishchenko TA; Vedunova MV; Krysko DV
    Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors.
    Qi J; Jin F; Xu X; Du Y
    Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Danger signalling during cancer cell death: origins, plasticity and regulation.
    Garg AD; Martin S; Golab J; Agostinis P
    Cell Death Differ; 2014 Jan; 21(1):26-38. PubMed ID: 23686135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.